Cost analysis and quality of life assessment comparing patients undergoing autologous peripheral blood stem cell transplantation or autologous bone marrow transplantation for refractory or relapsed non-Hodgkin's lymphoma or Hodgkin's disease-Reference-Cited by-同舟云学术

Cost analysis and quality of life assessment comparing patients undergoing autologous peripheral blood stem cell transplantation or autologous bone marrow transplantation for refractory or relapsed non-Hodgkin's lymphoma or Hodgkin's disease

Published:2001-09 Issue:14 Volume:37 Page:1781-1789
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

van Agthoven M,Vellenga E,Fibbe W.E,Kingma T,Uyl-de Groot C.A

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference30 articles.

1. High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin's lymphoma;Philip;N. Engl. J. Med.,1987

2. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma;Philip;N. Engl. J. Med.,1995

3. Granulocyte colony-stimulating factor accelerates neutrophil engraftment following peripheral-blood stem-cell transplantation;Klumpp;J. Clin. Oncol.,1995

4. Peripheral blood stem cell mobilization for high-dose chemotherapy;Demirer;J. Hematother.,1999

5. Randomized trial of peripheral blood progenitor cell vs bone marrow as hematopoietic support for high-dose chemotherapy in patients with non-Hodgkin's lymphoma and Hodgkin's disease;Kanteti;Bone Marrow Transplant,1999

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effect of hematopoietic stem cell transplantation on patient-reported subjective oral dryness: a systematic review focusing on prevalence, severity and distress;Supportive Care in Cancer;2023-07-08

2. Cryopreserved versus non-cryopreserved stem cell autografts in multiple myeloma a restrospective cohort study;Bone Marrow Transplantation;2022-05-30

3. Cost–effectiveness of brentuximab vedotin for the treatment of cutaneous T-cell lymphoma;Journal of Comparative Effectiveness Research;2022-02

4. EQ-5D–Derived Health State Utility Values in Hematologic Malignancies: A Catalog of 796 Utilities Based on a Systematic Review;Value in Health;2020-07

5. Brentuximab Vedotin for Treating Relapsed or Refractory CD30-Positive Cutaneous T-Cell Lymphoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal;PharmacoEconomics - Open;2020-03-23